Spotlight
Video

Can we predict which patients will benefit from Tarceva based on a blood test?

cancergrace has 1129 videos Subscribe Here

Loading........
Description: http://cancerGRACE.org/...

Drs. Mary Pinder, Nate Pennell, and Jack West review results from the PROSE trial presented at ASCO 2013, testing the predictive value of the Veristrat test of serum proteomics to assess the potential value of erlotinib (Tarceva) in advanced NSCLC.

GRACEcastUC 129 Lung
Shared By : cancergrace
Posted on : 06/13/13
Added : 6 years ago
Category : General